120 related articles for article (PubMed ID: 9783888)
21. Exclusive radiotherapy for stage T1-T2N0M0 lanryngeal cancer: retrospective study of 59 patients at CFB and CHU de Caen.
Cuny F; Géry B; Florescu C; Clarisse B; Blanchard D; Rame JP; Babin E; De Raucourt D
Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Nov; 130(5):251-6. PubMed ID: 23759281
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of radical radiotherapy alone for functional preservation of larynx in laryngeal carcinoma: a retrospective analysis.
Bhattacharyya T; Ghoshal S; Dhanireddy B; Kumar R; Sharma SC
Indian J Cancer; 2014; 51(1):10-4. PubMed ID: 24947088
[TBL] [Abstract][Full Text] [Related]
23. T1/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control.
Warde P; O'Sullivan B; Bristow RG; Panzarella T; Keane TJ; Gullane PJ; Witterick IP; Payne D; Liu FF; McLean M; Waldron J; Cummings BJ
Int J Radiat Oncol Biol Phys; 1998 May; 41(2):347-53. PubMed ID: 9607350
[TBL] [Abstract][Full Text] [Related]
24. Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma of the glottic larynx.
McLaughlin MP; Parsons JT; Fein DA; Stringer SP; Cassisi NJ; Mendenhall WM; Million RR
Head Neck; 1996; 18(3):229-35. PubMed ID: 8860763
[TBL] [Abstract][Full Text] [Related]
25. Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx?
Fein DA; Lee WR; Hanlon AL; Ridge JA; Curran WJ; Coia LR
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):823-31. PubMed ID: 8598359
[TBL] [Abstract][Full Text] [Related]
26. Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control.
Nishimura Y; Nagata Y; Okajima K; Mitsumori M; Hiraoka M; Masunaga S; Ono K; Shoji K; Kojima H
Radiother Oncol; 1996 Sep; 40(3):225-32. PubMed ID: 8940749
[TBL] [Abstract][Full Text] [Related]
27. Radiation therapy for management of t1-t2 glottic cancer at a private practice.
Jones DA; Mendenhall CM; Kirwan J; Morris CG; Donnan A; Holwerda S; Kraus ST; Mann CJ; Grant JR; Donnan B; Mendenhall WM
Am J Clin Oncol; 2010 Dec; 33(6):587-90. PubMed ID: 20051812
[TBL] [Abstract][Full Text] [Related]
28. Late local recurrence after radiotherapy for tongue and early glottic carcinoma.
Inoue T; Inoue T; Teshima T; Murayama S; Nose T; Tanaka E; Yamazaki H; Koizumi M; Kagawa K; Ozeki S; Ikeda H
Strahlenther Onkol; 1996 Jun; 172(6):301-5. PubMed ID: 8677501
[TBL] [Abstract][Full Text] [Related]
29. The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer.
Barton MB; Keane TJ; Gadalla T; Maki E
Radiother Oncol; 1992 Mar; 23(3):137-43. PubMed ID: 1574592
[TBL] [Abstract][Full Text] [Related]
30. Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy.
Murakami N; Mori T; Yoshimoto S; Ito Y; Kobayashi K; Ken H; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Sumi M; Itami J
Laryngoscope; 2014 Nov; 124(11):E431-6. PubMed ID: 25043563
[TBL] [Abstract][Full Text] [Related]
31. Overall time in telecobalt therapy for T1 glottic carcinoma treated with 2 Gy per day.
Inoue T; Inoue T; Teshima T; Murayama S; Yamazaki H; Nose T; Tanaka E
Strahlenther Onkol; 1995 Aug; 171(8):475-7. PubMed ID: 7652672
[TBL] [Abstract][Full Text] [Related]
32. Comparing treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: a comparison limited to patients eligible for surgery.
MacKenzie RG; Franssen E; Balogh JM; Gilbert RW; Birt D; Davidson J
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):65-71. PubMed ID: 10758306
[TBL] [Abstract][Full Text] [Related]
33. Feasibility and early results of accelerated radiotherapy for head and neck carcinoma in the elderly.
Allal AS; Maire D; Becker M; Dulguerov P
Cancer; 2000 Feb; 88(3):648-52. PubMed ID: 10649260
[TBL] [Abstract][Full Text] [Related]
34. Impact of radiation therapy fraction size on local control of early glottic carcinoma.
Yu E; Shenouda G; Beaudet MP; Black MJ
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):587-91. PubMed ID: 9112457
[TBL] [Abstract][Full Text] [Related]
35. Clinical assessment of tumor clearance during radiotherapy as a prognostic factor of early glottic carcinoma.
Inoue T; Inoue T; Ikeda H; Teshima T; Murayama S
Strahlenther Onkol; 1992 Oct; 168(10):579-83. PubMed ID: 1440229
[TBL] [Abstract][Full Text] [Related]
36. Modelling the optimal radiotherapy regime for the control of T2 laryngeal carcinoma using parameters derived from several datasets.
Roberts SA; Hendry JH; Slevin NJ
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1173-82. PubMed ID: 9392560
[TBL] [Abstract][Full Text] [Related]
37. The effect of differing radiotherapeutic schedules on the response of glottic carcinoma of the larynx.
Robertson AG; Robertson C; Boyle P; Symonds RP; Wheldon TE
Eur J Cancer; 1993; 29A(4):501-10. PubMed ID: 8435200
[TBL] [Abstract][Full Text] [Related]
38. Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.
Canaday DJ; Regine WF; Mohiuddin M; Zollinger W; Machtay M; Lee J; Schultz D; Rudoltz MS
Radiat Oncol Investig; 1999; 7(1):42-8. PubMed ID: 10030623
[TBL] [Abstract][Full Text] [Related]
39. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
[TBL] [Abstract][Full Text] [Related]
40. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease.
Cellai E; Frata P; Magrini SM; Paiar F; Barca R; Fondelli S; Polli C; Livi L; Bonetti B; Vitali E; De Stefani A; Buglione M; Biti G
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1378-86. PubMed ID: 16095847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]